CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro

Cancer Research and Treatment. 2019;51(1):43-52. Published online 2018 February 14 DOI: https://doi.org/10.4143/crt.2017.562

Cancer Research and Treatment. 2019;51(1):43-52

Link1

Link2 Link3

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

Mark Clemons, Anil A. Joy, Radhi Abdulnabi, Mauricio Kotliar, Jodi Lynch, Johan P. Jordaan, Neill Iscoe, Karen Gelmon

Breast Cancer Research and Treatment. 2010;124(1):177-186

Link1

Link2 Link3

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

M. Martin, M. Campone, I. Bondarenko, D. Sakaeva, S. Krishnamurthy, L. Roman, L. Lebedeva, J.-C. Vedovato, M. Aapro

Annals of Oncology. 2018;29(5):1195-1202

Link1 Link2 Link3

A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer

A.G. Pallis, I. Boukovinas, A. Ardavanis, I. Varthalitis, N. Malamos, V. Georgoulias, D. Mavroudis

Annals of Oncology. 2012;23(5):1164-1169

Link1 Link2 Link3

A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

Mario Campone, Natalya Dobrovolskaya, Serjei Tjulandin, Shin-Chen Chen, Sameul Fourie, Fawzia Mefti, Maria Konstantinova, Florence Lefresne, Nadege Meheust, Jacek Jassem

The Breast Journal. 2013;19(3):240-249

Link1 Link2

Gemcitabine plus docetaxel versus capecitabine plus docetaxel forpatients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial

Stephen Chan

European Journal of Cancer Supplements. 2005;3(5):17-21

Link1 Link2

A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP

Toshimi Takano, Junji Tsurutani, Masato Takahashi, Takeharu Yamanaka, Kazuko Sakai, Yoshinori Ito, Junya Fukuoka, Hideharu Kimura, Hidetaka Kawabata, Kenji Tamura, Koji Matsumoto, Kenjiro Aogi, Kazuhiko Sato, Kazuto Nishio, Kazuhiko Nakagawa, Toshiaki Saeki

The Breast. 2018;40:67-75

Link1 Link2

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

David Cunningham, Istvan Lang, Eugenio Marcuello, Vito Lorusso, Janja Ocvirk, Dong Bok Shin, Derek Jonker, Stuart Osborne, Niko Andre, Daniel Waterkamp, Mark P Saunders

The Lancet Oncology. 2013;14(11):1077-1085

Link1 Link2

Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer

Keun Seok Lee, In Hae Park, Byung-Ho Nam, Jungsil Ro

Investigational New Drugs. 2012;31(1):152-159

Link1

Link2 Link3 Link4

Cerebel (EGF111438): An Open Label Randomized Phase III Study Comparing the Incidence of CNS Metastases in Patients (PTS) with HER2+ Metastatic Breast Cancer (MBC), Treated with Lapatinib Plus Capecitabine (LC) Versus Trastuzumab Plus Capecitabine (TC)

X. Pivot, V. Semiglazov, B. Żurawski, R. Allerton, A. Fabi, E. Ciruelos, R. Parikh, M. DeSilvio, S. Santillana, R. Swaby

Annals of Oncology. 2012;23:ixe5

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.